About the Update
M&A activity in the medical device CDMO market remained resilient in H1 2026, with 19 completed transactions, slightly below the 20 deals recorded in H1 2025. While activity moderated from the peaks seen in the second halves of 2024 and 2025, early Q3 dealmaking indicates renewed appetite and growing confidence in the market.
Download the one-pager for latest medtech CDMO M&A insights, including H1 2026 data on:
- Recent M&A activity
- Geographic distribution of transactions
- Target manufacturing capabilities
- Target end markets
Click preview below to download!
Subscribe to our newsletter for the latest news, events, and thought leadership